Table 3.
Anatomical and functional outcomes at different follow-up intervals
| Variable | Baseline | 1 day | 1 month | 3 month | 6 month | 12 month |
|---|---|---|---|---|---|---|
| SSO groupa | ||||||
| IOP | 15.2 ± 3.1 | 22.8 ± 8.9 | 22.3 ± 7.4 | 20.5 ± 9.5 | 18.6 ± 8.4 | 16.7 ± 8.7 |
| Anatomical success rate (%) | 105 (100) | 98 (93) | 94 (89) | 92 (88) | 103 (98) | |
| BCVA logMar | 1.21 ± 0.94 | 1.01 ± 0.76 | 0.86 ± 0.35 | 0.94 ± 0.75 | 0.60 ± 0.54 | 0.56 ± 0.51 |
| Presence of SO (in/out) | 105/0 | 105/0 | 105/0 | 77/28 | 10/95 | 1/104 |
| Densiron 68 groupb | ||||||
| IOP | 14.8 ± 2.8 | 23.4 ± 5.7 | 21.8 ± 6.4 | 22.3 ± 9.2 | 18.9 ± 8.7 | 19.7 ± 3.8 |
| Anatomical success rate (%) | 75 (100) | 72 (96) | 68 (91) | 64 (85) | 74 (99) | |
| BCVA logMar | 1.74 ± 0.83 | 1.1 ± 0.79 | 0.78 ± 0.65 | 0.9 ± 0.84 | 0.68 ± 0.63 | 0.48 ± 0.81 |
| Presence of Densiron 68 (in/out) | 75/0 | 75/0 | 75/0 | 8/67 | 0/75 | 0/75 |
a
Notes: Mean time of SO removal was 160 ± 35 days;
b
Mean time of SO removal was 130 ± 15 days.
Abbreviations: SSO, standard silicone oil; IOP, intraocular pressure; BCVA, best corrected visual acuity.